SEP 14, 2021 9:00 AM PDT

Multiplex Bacterial PCR in Bronchoalveolar Lavage (BAL) - Does It Impact Inappropriate Antibiotic Use?

Sponsored by: OpGen
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Professor of Respiratory Medicine and leading physician at the University Hospital Basel, University of Basel, Switzerland
    BIOGRAPHY

Abstract
Date:  Spetember 14, 2021
Time: 9:00am (PDT),  12:00pm (EDT)
 
Pneumonia remains a major cause of morbidity and mortality. The use of broad-spectrum antibiotics is associated with the development of resistance, major side-effects and costs. Despite a higher sensitivity as compared to conventional microbiological diagnostics, molecular tests for bacterial lower respiratory infections are not well explored as a tool for enhancing antibiotic stewardship. This presentation will provide you the opportunity to review the rationale for using molecular diagnostics in bronchoalveolar lavage (BAL), to understand its role in the management of suspected lower respiratory tract infections, and to appreciate the newest results of a randomized trial evaluating the Unyvero multiplex bacterial PCR panel in BAL specimens to reduce inappropriate antibiotic therapy in patients hospitalized for pneumonia.
 
Learning Objectives
  • Recognize the challenges associated with microbiological diagnosis of lower respiratory tract infections (LRTI).
  • Discuss the new and available data on LRTI molecular testing and their important role in rapid and actionable diagnosis.
  • Demonstrate the impact of molecular diagnostics in bronchoalveolar lavage (BAL) specimens for reducing inappropriate antibiotic therapy in pneumonia.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
JUN 16, 2022 10:00 AM PDT
JUN 16, 2022 10:00 AM PDT
Date: June 16, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
Loading Comments...
Show Resources